HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Anton Hagenbeek Selected Research
Anton Hagenbeek Research Topics
Disease
22
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
05/2019 - 11/2002
16
Neoplasms (Cancer)
10/2021 - 11/2002
13
Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2019 - 11/2002
9
Lymphoma (Lymphomas)
12/2019 - 11/2002
8
Hodgkin Disease (Hodgkin's Disease)
10/2021 - 06/2003
7
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2019 - 01/2003
5
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2007 - 01/2002
3
B-Cell Lymphoma (Lymphoma, B Cell)
06/2011 - 06/2008
2
Residual Neoplasm
10/2021 - 11/2009
2
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2015 - 02/2009
2
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
07/2014 - 06/2008
2
Infections
06/2010 - 04/2006
2
Pathologic Complete Response
06/2010 - 06/2003
2
Leukemia
03/2005 - 05/2003
1
Fever (Fevers)
01/2021
1
Ototoxicity
01/2021
1
Disease Progression
05/2019
1
Febrile Neutropenia
06/2015
1
Neutropenia
06/2015
1
Rheumatoid Arthritis
07/2014
1
Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
02/2013
1
Bronchiolitis Obliterans Syndrome
11/2008
1
Agranulocytosis (Granulocytopenia)
04/2006
1
Hematologic Neoplasms (Hematological Malignancy)
03/2006
1
GATA2 Deficiency
01/2003
Drug/Important Bio-Agent (IBA)
19
Rituximab (Mabthera)
FDA Link
05/2019 - 11/2002
7
Biomarkers (Surrogate Marker)
IBA
12/2019 - 03/2007
7
Vincristine (Oncovin)
FDA Link
Generic
01/2017 - 01/2003
7
Prednisone (Sone)
FDA Link
Generic
01/2017 - 01/2003
6
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2017 - 01/2003
6
Monoclonal Antibodies
IBA
07/2014 - 06/2008
5
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2017 - 01/2003
4
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2021 - 02/2009
4
ofatumumab
FDA Link
02/2017 - 06/2008
3
Dexamethasone (Maxidex)
FDA Link
Generic
01/2021 - 02/2017
3
Cisplatin (Platino)
FDA Link
Generic
01/2021 - 02/2017
3
ibritumomab tiuxetan (Zevalin)
FDA Link
06/2013 - 11/2008
3
Yttrium-90
IBA
06/2013 - 11/2008
3
Antibodies
IBA
06/2011 - 07/2006
3
fludarabine
IBA
01/2009 - 02/2005
3
Ganciclovir (Cytovene)
FDA Link
Generic
10/2004 - 03/2003
2
Brentuximab Vedotin
IBA
01/2021 - 01/2019
2
polatuzumab vedotin
IBA
05/2019 - 06/2015
2
Biological Products
IBA
04/2014 - 04/2009
2
Complement System Proteins (Complement)
IBA
02/2013 - 06/2008
2
Epitopes
IBA
12/2010 - 05/2005
2
CD20 Antigens
IBA
08/2010 - 04/2010
2
Antigens
IBA
01/2007 - 06/2003
2
Therapeutic Uses
IBA
01/2007 - 06/2003
2
Thymidine Kinase
IBA
05/2003 - 03/2003
1
Cell-Free Nucleic Acids
IBA
10/2021
1
DNA (Deoxyribonucleic Acid)
IBA
10/2021
1
Enzymes
IBA
01/2021
1
pinatuzumab vedotin
IBA
05/2019
1
Genetic Markers (Genetic Marker)
IBA
01/2017
1
Immunoconjugates (Immunoconjugate)
IBA
06/2015
1
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
05/2010
1
Isoantibodies
IBA
11/2008
1
Autoantibodies
IBA
11/2008
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
06/2008
1
Pharmaceutical Preparations
IBA
02/2007
1
fludarabine phosphate (Fludara)
FDA Link
Generic
04/2006
1
Procarbazine (Matulane)
FDA Link
06/2003
1
Vinblastine (Vinblastine Sulfate)
FDA Link
06/2003
1
Mechlorethamine (Nitrogen Mustard)
FDA Link
06/2003
1
Bleomycin (Blenoxane)
FDA Link
Generic
06/2003
1
Alkylating Agents
IBA
01/2003
1
Mitoxantrone (Novantrone)
FDA Link
Generic
11/2002
1
Prednisolone (Predate)
FDA Link
Generic
11/2002
1
Chlorambucil (Leukeran)
FDA Link
11/2002
Therapy/Procedure
13
Drug Therapy (Chemotherapy)
01/2021 - 01/2003
12
Therapeutics
02/2017 - 11/2002
4
Salvage Therapy
01/2021 - 01/2007
4
Stem Cell Transplantation
02/2017 - 05/2003
3
Radiotherapy
11/2007 - 06/2003
2
Aftercare (After-Treatment)
10/2021 - 12/2009
2
Remission Induction
06/2010 - 11/2006
2
Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2004 - 01/2002
1
Immunotherapy
11/2008
1
Hematopoietic Stem Cell Transplantation
11/2008
1
Combined Modality Therapy
07/2006
1
Radioimmunotherapy
02/2005
1
Transplantation
01/2003